This dual activation enhances the immunostimulatory milieu, as seen in reduced tumor proliferation (via Ki67 staining) and increased cytokine production (e.g., CCL5, CXCL10, TNFα) in syngeneic models. The gene discussed is CXCL10; the disease is neoplasm.